Furthermore, Hu et al. demonstrated that Nrp1 expression by a subset of human glioma-derived xenografts potentiated their growth in an autocrine fashion via the amplification of pathways downstream of cMET and HGF [71]. This evidence concerns the gene NRP1 and central nervous system cancer.